Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP114866.RA7b1FHUVaKZTr45YPiIuFJFqas54U5ZhGOy8WyLqySZg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP114866.RA7b1FHUVaKZTr45YPiIuFJFqas54U5ZhGOy8WyLqySZg130_assertion type Assertion NP114866.RA7b1FHUVaKZTr45YPiIuFJFqas54U5ZhGOy8WyLqySZg130_head.
- NP114866.RA7b1FHUVaKZTr45YPiIuFJFqas54U5ZhGOy8WyLqySZg130_assertion description "[abnormal transcription of TACSTD2 and S100A2 are thought to be unique molecular markers of the preinvasive stage of lung adenocarcinoma ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP114866.RA7b1FHUVaKZTr45YPiIuFJFqas54U5ZhGOy8WyLqySZg130_provenance.
- NP114866.RA7b1FHUVaKZTr45YPiIuFJFqas54U5ZhGOy8WyLqySZg130_assertion evidence source_evidence_literature NP114866.RA7b1FHUVaKZTr45YPiIuFJFqas54U5ZhGOy8WyLqySZg130_provenance.
- NP114866.RA7b1FHUVaKZTr45YPiIuFJFqas54U5ZhGOy8WyLqySZg130_assertion SIO_000772 16232198 NP114866.RA7b1FHUVaKZTr45YPiIuFJFqas54U5ZhGOy8WyLqySZg130_provenance.
- NP114866.RA7b1FHUVaKZTr45YPiIuFJFqas54U5ZhGOy8WyLqySZg130_assertion wasDerivedFrom lhgdn-20090331 NP114866.RA7b1FHUVaKZTr45YPiIuFJFqas54U5ZhGOy8WyLqySZg130_provenance.
- NP114866.RA7b1FHUVaKZTr45YPiIuFJFqas54U5ZhGOy8WyLqySZg130_assertion wasGeneratedBy ECO_0000203 NP114866.RA7b1FHUVaKZTr45YPiIuFJFqas54U5ZhGOy8WyLqySZg130_provenance.